-- 
Japan Stocks: Advantest, Elpida, Marubeni, Olympus, Showa Denko

-- B y   Y o s h i a k i   N o h a r a
-- 
2011-10-13T06:12:47Z

-- http://www.bloomberg.com/news/2011-10-13/japan-stocks-canon-fast-retailing-marubeni-showa-denko.html
Japan ’s  Nikkei 225 (NKY)  Stock Average
rose 84.35 or 1 percent, to 8,823.25 as of the 3 p.m. trading
close in Tokyo. The following are among the most active shares
in the Japanese market today. Stock symbols are in parentheses
after company names.  Semiconductor-related companies gained after ASML Holding
NV,  Europe ’s biggest equipment maker in the sector, said fourth-
quarter orders will increase as customers add capacity and
upgrade to more advanced machines.  Advantest Corp. (6857)  (6857 JT), a maker of memory-chip testers,
rose 5.6 percent to 889 yen.  Elpida Memory Inc. (6665)  (6665 JT), a
maker of semiconductors, advanced 4 percent to 552 yen.  Marubeni Corp. (8002)  (8002 JT), a Japanese trading company,
gained 2.6 percent to 430 yen. Marubeni and Teekay LNG Partners
LP are acquiring a liquefied natural gas tanker unit of A.P.
Moeller-Maersk A/S for $1.4 billion in cash.  Olympus Corp. (7733)  (7733 JT), an optical-equipment maker, rose
4.6 percent to 2,482 yen. Goldman Sachs Group Inc. raised the
company’s rating to “buy” from “neutral” and boosted the
target price for the next two years to 3,800 yen from 2,400 yen.
Profitability will increase dramatically over the next few years
because of Olympus’s competitive advantage in the endoscope
market as the company transforms into a global medical equipment
supplier, Goldman said in a report today.  Showa Denko K.K. (4004 JT), a producer of chemical products,
rose 2.7 percent to 154 yen. The company’s operating profit this
year through September is likely to rise 31 percent to 36
billion yen from a year earlier, the Nikkei newspaper reported
without naming a source.  Taisho Pharmaceutical Holdings Co. (4581 JT) fell 5.5
percent to 6,070 yen. The company cut its net income forecast 18
percent to 11.5 billion yen for the period ended in September.  To contact the reporter on this story:
Yoshiaki Nohara in  Tokyo  at 
 ynohara1@bloomberg.net   To contact the editor responsible for this story:
Nick Gentle at 
 ngentle2@bloomberg.net  